BACKGROUND AND PURPOSE: Adaptive strategies in radiotherapy (RT) require the knowledge of the total dose given to every organ of the body. Because of anatomical changes and setup errors non-rigid registration is necessary to map the different dose fractions to a common reference. This study evaluates practically if the accumulation of all of these registered dose fractions must take radiobiology into account in a classical clinical setting. MATERIALS AND METHODS: Ten patients with head and neck tumors treated by chemo-RT were used. Contrast-enhanced CT scans were acquired prior and during RT following delivery of mean doses of 14.2, 24.5, 35.0 and 44.9Gy and the planned pre-treatment helical tomotherapy sinograms were applied on the per-tre...
Parotid gland (PG) shrinkage and neck volume reduction during radiotherapy of head and neck (H&N...
Introduction Patients with virally mediated head and neck cancer (VMHNC) often present with advanced...
Introduction: Patients with virally mediated head and neck cancer (VMHNC) often present with advance...
Background and purpose: Anatomical changes induce differences between planned and delivered dose. Ad...
Introduction: This study evaluates treatment plans aiming at determining the expected impact of dai...
Background and purpose: Adaptive radiotherapy (ART) decision-making benefits from dosimetric informa...
Delivered radiation dose can differ from intended dose. This study quantifies dose deterioration in ...
PURPOSE: To estimate the delivered dose to targets and organs at risk for head and neck radiation th...
Background Patient positioning during a course of external beam radiotherapy (EBRT) can be verified...
Background/Objective: The dose distribution is affected by tissue inhomogeneities. The ob-jective of...
Over the years, it has been recognized that using pre-treatment imaging as a “snapshot” of the tumor...
Background Patient positioning during a course of external beam radiotherapy (EBRT) can be verified ...
Many head-and-neck cancer (HNC) patients treated with radiotherapy suffer significant anatomical cha...
Purpose: The anatomical changes, which occur during the radiotherapy treatment for head-and-neck can...
Includes bibliographical references (p. 34-36)Head and neck cancers are among the most complex sites...
Parotid gland (PG) shrinkage and neck volume reduction during radiotherapy of head and neck (H&N...
Introduction Patients with virally mediated head and neck cancer (VMHNC) often present with advanced...
Introduction: Patients with virally mediated head and neck cancer (VMHNC) often present with advance...
Background and purpose: Anatomical changes induce differences between planned and delivered dose. Ad...
Introduction: This study evaluates treatment plans aiming at determining the expected impact of dai...
Background and purpose: Adaptive radiotherapy (ART) decision-making benefits from dosimetric informa...
Delivered radiation dose can differ from intended dose. This study quantifies dose deterioration in ...
PURPOSE: To estimate the delivered dose to targets and organs at risk for head and neck radiation th...
Background Patient positioning during a course of external beam radiotherapy (EBRT) can be verified...
Background/Objective: The dose distribution is affected by tissue inhomogeneities. The ob-jective of...
Over the years, it has been recognized that using pre-treatment imaging as a “snapshot” of the tumor...
Background Patient positioning during a course of external beam radiotherapy (EBRT) can be verified ...
Many head-and-neck cancer (HNC) patients treated with radiotherapy suffer significant anatomical cha...
Purpose: The anatomical changes, which occur during the radiotherapy treatment for head-and-neck can...
Includes bibliographical references (p. 34-36)Head and neck cancers are among the most complex sites...
Parotid gland (PG) shrinkage and neck volume reduction during radiotherapy of head and neck (H&N...
Introduction Patients with virally mediated head and neck cancer (VMHNC) often present with advanced...
Introduction: Patients with virally mediated head and neck cancer (VMHNC) often present with advance...